Clinical Trial Update: A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for SHR-A1921 with or without carboplatin in ovarian cancer is in Phase 2/Phase 3 and not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• SHR-A1921

Snippet

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Conditions: Ovarian Cancer | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING